An interventional study of miss alice face it you love me serum and No treatment (usual skincare rutine) in Skin Hyperpigmentation and Dry Skin; Eczema, sponsored by University of Split, School of Medicine. Recruiting at 1 site in Croatia. Per ClinicalTrials.gov, last updated 2024-01-03.
Sponsored by University of Split, School of Medicine · Not applicable, Interventional, and Treatment
Niacinamide in lower concentrations has been recognized as a cosmetic ingredient with hydrating properties. Therefore, aim was to test the efficacy and safety of niacinamide cosmetic preparation in A Randomized, Controlled Trial.
Skin hydration (as use of hydrating cosmetic ingredients) is one of the most interventions for healthy skin and skin barrier function. Therefore, cosmetic ingredients used for this purpose should be examined for their efficacy.
127 studies on the registry are indexed under Hyperpigmentation; 28 are open to participants now.
This study's planned enrollment of 25 is below the median of 32 across 113 interventional studies indexed under Hyperpigmentation.
Browse Hyperpigmentation studies →University of Split, School of Medicine is the lead sponsor of 51 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Use of facial serum with niacinamide, plant-based collagen and peptides on randomized site on forehead
Other: miss alice face it you love me serum
No treatment (usual skincare rutine)
Other: No treatment (usual skincare rutine)
Facial serum with niacinamide, plant-based collagen and peptides will be applied by each participant to the treatment site according to randomization protocol every evening
No treatment (usual skincare rutine)
TEWL assessment with Courage Khazaka probe
Transepidermal water loss
Time frame: through study completion, an average of 1 year
Hydration assessment with corneometer probe
stratum corneum hydration
Time frame: through study completion, an average of 1 year
pigmentation assessment with mexameter probe
erythema and melanin
Time frame: through study completion, an average of 1 year
skin oiliness assessment with sebumeter probe
sebum level
Time frame: through study completion, an average of 1 year
subjective opinion of participants
participants notes on skin rection
Time frame: through study completion, an average of 1 year
Plan to share: Yes — upon request
Supporting information: Clinical study report
Time frame: upon request
Access criteria: upon request
No publications or documents are linked to this record.
Started Jun 2023 (actual). Primary completion is estimated for Jun 2024, 11 months after the start.
Of 37 non-industry interventional studies with no phase under Hyperpigmentation, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 11 months is close to that.
Counting every sponsor, half of 64 studies reached it within 7 months; a quarter within 3 and three quarters within 25.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Split, School of Medicine